Borchmann P, Goergen H, Kobe C, et al. Treatment reduction in patients with advanced-stage Hodgkin lymphoma and negative interim PET: final results of the international, randomized phase 3 trial HD18 by the German Hodgkin Study Group. EHA 2017, abstract S150.
THEMIS2-expressie verbetert voorspelling time-to-first-treatment bij CLL
jan 2024 | Leukemie